Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclodialysis in the treatment of glaucoma.

American journal of ophthalmology·2010
Same author

Scleral necrosis in periarteritis nodosa; a case report.

American journal of ophthalmology·2010
Same author

Scleral necrosis associated with periarteritis nodosa; report of a case.

Archives of ophthalmology (Chicago, Ill. : 1929)·2010
Same author

Surgical repair and histopathologic features of a dissecting glaucoma filtration bleb.

Archives of ophthalmology (Chicago, Ill. : 1960)·1999
Same author

Analysis of the 60 S ribosomal protein L27a (L29) gene of Trypanosoma brucei.

International journal for parasitology·1999
Same author

Irreversible corneal decompensation in patients treated with topical dorzolamide.

American journal of ophthalmology·1999

Related Experiment Video

Updated: Jul 17, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Intraocular pressure after intracapsular cataract extraction.

S V Brown, J G Tye, S D McPherson

    Ophthalmic Surgery
    |May 1, 1984
    PubMed
    Summary

    Postoperative intraocular pressure spikes are common after cataract surgery. Timolol maleate eye drops offered a slight reduction but did not prevent these pressure elevations.

    Area of Science:

    • Ophthalmology
    • Surgical Outcomes
    • Pharmacology

    Background:

    • Intracapsular cataract extraction (ICCE) is a surgical procedure for cataract removal.
    • Postoperative intraocular pressure (IOP) elevation is a known complication following ophthalmic surgery.
    • Alpha-chymotrypsin is an enzyme used during ICCE to facilitate lens removal.

    Purpose of the Study:

    • To investigate the incidence of postoperative intraocular pressure elevations after ICCE using alpha-chymotrypsin.
    • To evaluate the efficacy of a single postoperative instillation of timolol maleate 0.5% in mitigating these pressure elevations.

    Main Methods:

    • A cohort of 42 patients undergoing ICCE with alpha-chymotrypsin was studied.
    • Intraocular pressure was monitored within 48 hours postoperatively.

    More Related Videos

    Modeling Cataract Surgery in Mice
    05:19

    Modeling Cataract Surgery in Mice

    Published on: December 1, 2023

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
    04:36

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

    Published on: April 14, 2026

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
    04:59

    Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

    Published on: July 7, 2023

    Modeling Cataract Surgery in Mice
    05:19

    Modeling Cataract Surgery in Mice

    Published on: December 1, 2023

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
    04:36

    Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

    Published on: April 14, 2026

  • A subset of patients received a single immediate postoperative instillation of timolol maleate 0.5%.
  • Main Results:

    • 17% of patients developed IOP greater than 30 mm Hg.
    • 38% of patients experienced IOP greater than 24 mm Hg within 48 hours.
    • Timolol maleate 0.5% showed a minor IOP-lowering effect at 3 and 6 hours but did not prevent pressure spikes.

    Conclusions:

    • Significant intraocular pressure elevations occur frequently after ICCE with alpha-chymotrypsin.
    • Immediate postoperative timolol maleate 0.5% is insufficient to prevent postoperative IOP spikes.
    • Further investigation into IOP management strategies post-ICCE is warranted.